[email protected]

Kristof Zsolt Szalay is Founder and CTO of Turbine.ai, a simulation-driven drug discovery company - and guest contributor for Emerj Artificial Intelligence Research. Kristof holds a PhD in molecular biology and bioinformatics from Semmelweis University.

Articles by Test

1 articles
The AI Behind DeepMind's Alphafold 950x540

The AI Behind DeepMind’s AlphaFold – and its Implications for the Future of Drug Discovery

This is a contributed article by Kristóf Zsolt Szalay. Kristóf is Founder and CTO at Turbine.AI, and holds a PhD in molecular biology and bioinformatics. To inquire about contributed articles from outside experts, contact [email protected]

Stay Ahead of the Machine Learning Curve

Join over 20,000 AI-focused business leaders and receive our latest AI research and trends delivered weekly.

Thanks for subscribing to the Emerj "AI Advantage" newsletter, check your email inbox for confirmation.